HEINEKEN® 0.0 UNVEILS FIRST ZERO ALCOHOL, ZERO CALORIE, AND ZERO SUGAR BREW
Pioneer in non-alcoholic beer introduces Heineken 0.0 Ultimate, a new great tasting alcohol-free option for mindful drinkers
Now more than ever, consumers are refusing to choose between their lifestyle goals and their social lives. Demand for non-alcoholic options that fit into active social moments, from the padel court to a sun-soaked afternoon, is stronger than ever. According to a Brewers Association study, the non-alcoholic beer category has surged in recent years, with
Driven by younger, health-conscious consumers and "sober curious" trends, interest in zero and lower calorie drink offerings is accelerating. With its zero-calorie and zero-sugar proposition, Heineken 0.0 Ultimate meets this modern need with a premium, great-tasting non-alcoholic brew designed for today's social occasions.
"We pioneered the
Heineken 0.0 Ultimate features soft fruity notes, harmonized with a delicate malty body, all without alcohol, calories, and sugar. Double-brewed to remove alcohol, it delivers a fresh, balanced taste with a refined mouthfeel and refreshing snap, made for daytime hangs and active moments.
After successfully piloting the brew in 2025, Heineken 0.0 Ultimate is rolling out in select states including NY, DE, RI, PA, NH, CT, ME, MD, TX, FL, LA, OK, WA, OR, VT. For more information and to find a retailer near you, please visit www.heineken.com.
About HEINEKEN USA
HEINEKEN USA Inc., is a subsidiary of HEINEKEN International N.V., the world's most international brewer. Key brands in the
Media Contact:
View original content to download multimedia:https://www.prnewswire.com/news-releases/heineken-0-0-unveils-first-zero-alcohol-zero-calorie-and-zero-sugar-brew-302712409.html
SOURCE Heineken USA
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Insurance Agent Nick Hogan Explains What First-Time Homeowners Often Miss About Homeowners Insurance in HelloNation
- Le Comble Reports MOVA Residences by B&B Italia Reaches 75% Sold in Panama City
- Phase III ARTEMIS-008 Trial Shows Risvutatug Rezetecan Significantly Improves Overall Survival in Relapsed Small-Cell Lung Cancer
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share